(a) Beiderbeck, H.; Taraz, K.; Budzikiewicz, H.; Walsby, A. E. Z. Naturforsch. 2000, 55c, 681â687. There is no corresponding record for this referen...
The Australian School of Advanced Medicine, Macquarie University, NSW 2109, Australia. ⥠School of ... Australian Sports Drug Testing Laboratory, National Measurement Institute, NSW 2073, Australia. # Faculty of ..... Tristan A. Reekie , Shane M. W
Oct 23, 2017 - Department of Radiology, Duke University Medical Center, Durham, North ..... UNMC for assistance using the EVOS FL Cell Imaging System;.
Crystallographic analysis has established the ... if the dimer failed to bisintercalate, it could potentially exert inhibitory effects by ... reported compound 1,13 camptothecin (2), and previously reported ... to the methods outlined in Scheme 2, pr
Jan 24, 2008 - George R. Pettit , Qinghua Ye , Delbert L. Herald , Fiona Hogan and Robin K. Pettit ... Amos B. Smith , III , Richard J. Fox and Thomas M. Razler.
Dec 22, 2016 - Zhaolin Wang, Susan Low, and Kevin A. McDonnell*. BIND Therapeutics, 325 Vassar Street, Cambridge, Massachusetts 02139, United States.
The small guanosine 5'-triphosphate (GTP) binding protein p21 Ras and the serine/threonine protein kinase Raf-1 play a pivotal, regulatory role in oncogenic, ...
May 20, 2014 - DHβE is one of the most potent nAChR antagonists of this class and ..... Lippiello , P. M. Nicotinic cholinergic antagonists: a novel approach for ...
Feb 5, 2018 - ABSTRACT: Nine pyridyloxypyridyl indole carboxamides were synthesized and displayed high affinities for 5-HT2C receptors and high ...
Osteoporosis and related bone metabolic diseases have emerged as ... for bone diseases such as osteoporosis.10 Although PGE2 is a strong anabolic agent, ...
(a) Beiderbeck, H.; Taraz, K.; Budzikiewicz, H.; Walsby, A. E. Z. Naturforsch. 2000, 55c, 681â687. There is no corresponding record for this reference.
